Cargando…

Clinical relevance of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation

Donor-specific human leukocyte antigen (HLA) antibodies (DSAs) have a significant role in graft survival after pediatric liver transplantation. To understand the significance of DSAs, a retrospective cohort study of 48 pediatric liver transplant recipients with posttransplant serum samples that were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Wang, Kai, Xiao, Yan-Li, Liu, Chun, Gao, Wei, Li, Dai-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237393/ https://www.ncbi.nlm.nih.gov/pubmed/34194545 http://dx.doi.org/10.3892/etm.2021.10299

Ejemplares similares

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020)

Clinical relevance of a CD4(+) T cell immune function assay in the diagnosis of infection in pediatric living-donor liver transplantation
por: Liu, Wei, et al.
Publicado: (2019)

Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients
por: Jahnukainen, Timo, et al.
Publicado: (2019)

Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study
por: Ogawa, Kohei, et al.
Publicado: (2023)

Donor-Specific Antibodies Against Donor Human Leukocyte Antigen are Associated with Graft Inflammation but Not with Fibrosis Long-Term After Liver Transplantation: An Analysis of Protocol Biopsies
por: Gül-Klein, Safak, et al.
Publicado: (2021)

The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation
por: Tajima, Tetsuya, et al.
Publicado: (2022)

Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation
por: Peng, Bo, et al.
Publicado: (2019)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)

Impact of the Trough Level of Calcineurin Inhibitor on the Prevalence of Donor-Specific Human Leukocyte Antigen Antibodies During Long-Term Follow-Up After Pediatric Liver Transplantation: Antibody Strength and Complement-Binding Ability
por: Tokodai, Kazuaki, et al.
Publicado: (2017)

Prevalence of Donor-Specific Antibodies After Pediatric Liver Transplantation: A Meta-Analysis.
por: Kivelä, Jesper M.
Publicado: (2016)

Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation
por: Schotters, Felicitas Leonie, et al.
Publicado: (2021)

Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhao, Xiaosu, et al.
Publicado: (2017)

Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation
por: Zhang, Xiaohai, et al.
Publicado: (2017)

Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation
por: Aldridge, RW, et al.
Publicado: (2015)

Human leukocyte antigen antibody incompatible renal transplantation
por: Krishnan, N. S., et al.
Publicado: (2012)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Outcomes of Liver Transplantation Using Pediatric Deceased Donor Livers: A Single-Center Analysis of 102 Donors
por: Zhang, Rui, et al.
Publicado: (2018)

Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation
por: HU, WEI-YU, et al.
Publicado: (2014)

Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023)

Impact of donor age on short-term outcomes after pediatric split liver transplantation
por: Xu, Min, et al.
Publicado: (2023)

The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
por: Goto, Ryoichi, et al.
Publicado: (2022)

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets
por: Chang, Ying-Jun, et al.
Publicado: (2015)

Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience
por: Kang, Hyunhye, et al.
Publicado: (2021)

Donor-Specific Human Leukocyte Antigen Antibody Formation After Allograft Glenoid Reconstruction Occurs But Does Not Impact Clinicoradiographic Outcomes
por: Liwski, Daniel R., et al.
Publicado: (2021)

COVID-19 in a pediatric heart transplant recipient: Emergence of donor-specific antibodies
por: Russell, Matthew R., et al.
Publicado: (2020)

Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation
por: Phanish, M. K.
Publicado: (2016)

Acquired diaphragmatic hernia in pediatrics after living donor liver transplantation: Three cases report and review of literature
por: Wang, Kai, et al.
Publicado: (2018)

Immunology and Donor-Specific Antibodies in Corneal Transplantation
por: Major, Joanna, et al.
Publicado: (2021)

Korea-nationwide incidence of pediatric deceased donors and single-institutional status of liver transplantation using pediatric donor liver grafts
por: Namgung, Jung-Man, et al.
Publicado: (2020)

Successful treatment of early acute antibody-mediated rejection in an human leukocyte antigen-incompatible and ABO-incompatible living-donor kidney transplant patient
por: Gang, Sujin, et al.
Publicado: (2019)

Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome
por: Molina, Juan, et al.
Publicado: (2017)

Long-term mycophenolate monotherapy in human leukocyte antigen (HLA)-identical living-donor kidney transplantation
por: Gascó, Blanca, et al.
Publicado: (2014)

Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome
por: Meneghini, Maria, et al.
Publicado: (2018)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
por: Lee, Wei-Chen, et al.
Publicado: (2021)

Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study
por: Bouatou, Yassine, et al.
Publicado: (2018)

Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation
por: Wu, Ming-Kung, et al.
Publicado: (2018)

Outcomes of Patients with Benign Liver Diseases Undergoing Living Donor versus Deceased Donor Liver Transplantation
por: Li, Chuan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3kunfa9rejfjko9kgicqte1i86